{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:03:59Z","timestamp":1769504639155,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00702-024-02815-w","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T16:02:01Z","timestamp":1723219321000},"page":"117-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glutathione S-transferase polymorphisms (GSTM1\/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"132","author":[{"given":"Ali Barreh","family":"Guedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sghaier","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abida","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gharbi","family":"Alya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souissi","family":"Amira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrabet","family":"Saloua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasri","family":"Amina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Djebara","family":"Mouna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kacem","family":"Imen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gargouri-Berrechid","family":"Amina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gouider","family":"Riadh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"2815_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1006\/bbrc.2000.2338","volume":"269","author":"A Ahmadi","year":"2000","unstructured":"Ahmadi A, Fredrikson M, Jerreg\u00e5rd H et al (2000) GSTM1 and mEPHX polymorphisms in Parkinson\u2019s Disease and Age of Onset. Biochem Biophys Res Commun 269:676\u2013680. https:\/\/doi.org\/10.1006\/bbrc.2000.2338","journal-title":"Biochem Biophys Res Commun"},{"key":"2815_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/mds.27864","volume":"34","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Ahmed S, Sabir MS et al (2019) The Genetic Architecture of Parkinson Disease in Spain: characterizing Population-Specific Risk, Differential Haplotype structures, and providing Etiologic Insight. Mov Disord 34:1851\u20131863. https:\/\/doi.org\/10.1002\/mds.27864","journal-title":"Mov Disord"},{"key":"2815_CR3","doi-asserted-by":"publisher","unstructured":"Barreh GA, Sghaier I, Abida Y et al (1713798001) LRRK2 G2019S impact on Parkinson disease; clinical phenotype and treatment in Tunisian patients. JMD. https:\/\/doi.org\/10.14802\/jmd.23276","DOI":"10.14802\/jmd.23276"},{"key":"2815_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s40478-020-01090-6","volume":"8","author":"MF Beal","year":"2020","unstructured":"Beal MF, Chiluwal J, Calingasan NY et al (2020) Isotope-reinforced polyunsaturated fatty acids improve Parkinson\u2019s disease-like phenotype in rats overexpressing \u03b1-synuclein. Acta Neuropathol Commun 8:220. https:\/\/doi.org\/10.1186\/s40478-020-01090-6","journal-title":"Acta Neuropathol Commun"},{"key":"2815_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JAD-170222","volume":"60","author":"S Ben Jemaa","year":"2017","unstructured":"Ben Jemaa S, Attia Romdhane N, Bahri-Mrabet A et al (2017) An Arabic Version of the Cognitive Subscale of the Alzheimer\u2019s Disease Assessment Scale (ADAS-Cog): reliability, validity, and normative data. J Alzheimers Dis 60:11\u201321. https:\/\/doi.org\/10.3233\/JAD-170222","journal-title":"J Alzheimers Dis"},{"key":"2815_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.eplepsyres.2014.05.009","volume":"108","author":"C Chbili","year":"2014","unstructured":"Chbili C, B\u2019chir F, Ben Fredj M et al (2014) Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among a Tunisian population. Epilepsy Res 108:1168\u20131173. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.05.009","journal-title":"Epilepsy Res"},{"key":"2815_CR7","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308\u20132314. https:\/\/doi.org\/10.1212\/wnl.44.12.2308","journal-title":"Neurology"},{"key":"2815_CR8","doi-asserted-by":"publisher","unstructured":"Deliz JR, Tanner CM, Gonzalez-Latapi P (2024) Epidemiology of Parkinson\u2019s Disease: an update. https:\/\/doi.org\/10.1007\/s11910-024-01339-w. Curr Neurol Neurosci Rep","DOI":"10.1007\/s11910-024-01339-w"},{"key":"2815_CR9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/wnl.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621\u20131626. https:\/\/doi.org\/10.1212\/wnl.55.11.1621","journal-title":"Neurology"},{"key":"2815_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajp.2012.02.023","volume":"5","author":"T Ghosh","year":"2012","unstructured":"Ghosh T, Mustafa Md, Kumar V et al (2012) A preliminary study on the influence of glutathione S transferase T1 (GSTT1) as a risk factor for late onset Alzheimer\u2019s disease in north Indian population. Asian J Psychiatry 5:160\u2013163. https:\/\/doi.org\/10.1016\/j.ajp.2012.02.023","journal-title":"Asian J Psychiatry"},{"key":"2815_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"2815_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/87565648709540361","volume":"3","author":"E Grober","year":"1987","unstructured":"Grober E, Buschke H (1987) Genuine memory deficits in dementia. Dev Neuropsychol 3:13\u201336. https:\/\/doi.org\/10.1080\/87565648709540361","journal-title":"Dev Neuropsychol"},{"key":"2815_CR13","doi-asserted-by":"publisher","first-page":"102114","DOI":"10.1016\/j.pneurobio.2021.102114","volume":"204","author":"M Huang","year":"2021","unstructured":"Huang M, Chen S (2021) DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application. Prog Neurobiol 204:102114. https:\/\/doi.org\/10.1016\/j.pneurobio.2021.102114","journal-title":"Prog Neurobiol"},{"key":"2815_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach M-A, Antonini A et al (2023) Levodopa Dose Equivalency in Parkinson\u2019s Disease: updated systematic review and proposals. Mov Disord 38:1236\u20131252. https:\/\/doi.org\/10.1002\/mds.29410","journal-title":"Mov Disord"},{"key":"2815_CR15","doi-asserted-by":"publisher","unstructured":"Kang W-Y, Yang Q, Jiang X-F et al (2014) Salivary DJ-1 could be an indicator of parkinson\u2019s disease progression. Front Aging Neurosci 6. https:\/\/doi.org\/10.3389\/fnagi.2014.00102","DOI":"10.3389\/fnagi.2014.00102"},{"key":"2815_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.parkreldis.2010.04.009","volume":"16","author":"C Kiyohara","year":"2010","unstructured":"Kiyohara C, Miyake Y, Koyanagi M et al (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson\u2019s disease in a Japanese population. Parkinsonism Relat Disord 16:447\u2013452. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.04.009","journal-title":"Parkinsonism Relat Disord"},{"key":"2815_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/mds.26237","volume":"30","author":"CM Lill","year":"2015","unstructured":"Lill CM, Hansen J, Olsen JH et al (2015) Impact of Parkinson\u2019s disease risk loci on age at onset. Mov Disord 30:847\u2013850. https:\/\/doi.org\/10.1002\/mds.26237","journal-title":"Mov Disord"},{"key":"2815_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/NDT.S376942","volume":"19","author":"H Liu","year":"2023","unstructured":"Liu H, Xu Y, Peng J (2023) ) <\u2009em\u2009>\u2009glutathione S-Transferase M1\/<em\u2009>\u2009T1\u2009polymorphisms and Schizophrenia Risk: a New Method for Quality Assessment and a systematic Review<\/em\u2009>. NDT 19:97\u2013107. https:\/\/doi.org\/10.2147\/NDT.S376942","journal-title":"NDT"},{"key":"2815_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13041-022-00964-1","volume":"15","author":"AS Mihaescu","year":"2022","unstructured":"Mihaescu AS, Valli M, Uribe C et al (2022) Beta amyloid deposition and cognitive decline in Parkinson\u2019s disease: a study of the PPMI cohort. Mol Brain 15:79. https:\/\/doi.org\/10.1186\/s13041-022-00964-1","journal-title":"Mol Brain"},{"key":"2815_CR20","doi-asserted-by":"publisher","first-page":"e27883","DOI":"10.1371\/journal.pone.0027883","volume":"6","author":"A Miyama","year":"2011","unstructured":"Miyama A, Saito Y, Yamanaka K et al (2011) Oxidation of DJ-1 Induced by 6-Hydroxydopamine decreasing intracellular glutathione. PLoS ONE 6:e27883. https:\/\/doi.org\/10.1371\/journal.pone.0027883","journal-title":"PLoS ONE"},{"key":"2815_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1089\/omi.2022.0090","volume":"26","author":"G Nakanishi","year":"2022","unstructured":"Nakanishi G, Pita-Oliveira M, Bertagnolli LS et al (2022) Worldwide systematic review of GSTM1 and GSTT1 null genotypes by continent, ethnicity, and therapeutic area. OMICS 26:528\u2013541. https:\/\/doi.org\/10.1089\/omi.2022.0090","journal-title":"OMICS"},{"key":"2815_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-genome wide association study. Lancet Neurol 18:1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"key":"2815_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1532-5415.2008.02096.x","volume":"57","author":"S Nazem","year":"2009","unstructured":"Nazem S, Siderowf AD, Duda JE et al (2009) Montreal cognitive assessment performance in patients with Parkinson\u2019s disease with normal global cognition according to mini-mental state examination score. J Am Geriatr Soc 57:304\u2013308. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02096.x","journal-title":"J Am Geriatr Soc"},{"key":"2815_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-024-00703-4","volume":"10","author":"KJ Ngo","year":"2024","unstructured":"Ngo KJ, Paul KC, Wong D et al (2024) Lysosomal genes contribute to Parkinson\u2019s disease near agriculture with high intensity pesticide use. npj Parkinsons Dis 10:1\u201310. https:\/\/doi.org\/10.1038\/s41531-024-00703-4","journal-title":"npj Parkinsons Dis"},{"key":"2815_CR25","doi-asserted-by":"publisher","first-page":"175628642211080","DOI":"10.1177\/17562864221108018","volume":"15","author":"D Nyholm","year":"2022","unstructured":"Nyholm D, Jost WH (2022) Levodopa\u2013entacapone\u2013carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance. Ther Adv Neurol Disord 15:17562864221108018. https:\/\/doi.org\/10.1177\/17562864221108018","journal-title":"Ther Adv Neurol Disord"},{"key":"2815_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s002040050527","volume":"72","author":"B Oke","year":"1998","unstructured":"Oke B, Akbas F, Aydin M, Berkkan H (1998) GSTT1 null genotype frequency in a Turkish population. Arch Toxicol 72:454\u2013455. https:\/\/doi.org\/10.1007\/s002040050527","journal-title":"Arch Toxicol"},{"key":"2815_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1749-6632.1996.tb39064.x","volume":"786","author":"AD Owen","year":"1996","unstructured":"Owen AD, Schapira AH, Jenner P, Marsden CD (1996) Oxidative stress and Parkinson\u2019s disease. Ann N Y Acad Sci 786:217\u2013223. https:\/\/doi.org\/10.1111\/j.1749-6632.1996.tb39064.x","journal-title":"Ann N Y Acad Sci"},{"key":"2815_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/NRE-141057","volume":"34","author":"KC Pagliarin","year":"2014","unstructured":"Pagliarin KC, Ortiz KZ, de Parente MA MP, et al (2014) Montreal-Toulouse language assessment battery for aphasia: validity and reliability evidence. NeuroRehabilitation 34:463\u2013471. https:\/\/doi.org\/10.3233\/NRE-141057","journal-title":"NeuroRehabilitation"},{"key":"2815_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"2815_CR30","first-page":"783","volume":"54","author":"TS Prabha","year":"2016","unstructured":"Prabha TS, Kumaraswami K, Kutala VK (2016) Association of GSTT1 and GSTM1 polymorphisms in South Indian Epilepsy patients. Indian J Exp Biol 54:783\u2013787","journal-title":"Indian J Exp Biol"},{"key":"2815_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.neurol.2020.03.013","volume":"177","author":"A Rebai","year":"2021","unstructured":"Rebai A, Chbili C, Ben Amor S et al (2021) Effects of glutathione S-transferase M1 and T1 deletions on Parkinson\u2019s disease risk among a north African population. Rev Neurol 177:290\u2013295. https:\/\/doi.org\/10.1016\/j.neurol.2020.03.013","journal-title":"Rev Neurol"},{"key":"2815_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(23)00283-1","volume":"22","author":"M Rizig","year":"2023","unstructured":"Rizig M, Bandres-Ciga S, Makarious MB et al (2023) Identification of genetic risk loci and causal insights associated with Parkinson\u2019s disease in African and African admixed populations: a genome-wide association study. Lancet Neurol 22:1015\u20131025. https:\/\/doi.org\/10.1016\/S1474-4422(23)00283-1","journal-title":"Lancet Neurol"},{"key":"2815_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mdc3.12511","volume":"4","author":"S Schade","year":"2017","unstructured":"Schade S, Sixel-D\u00f6ring F, Ebentheuer J et al (2017) Acute Levodopa Challenge Test in patients with de novo Parkinson\u2019s disease: data from the DeNoPa Cohort. Mov Disord Clin Pract 4:755\u2013762. https:\/\/doi.org\/10.1002\/mdc3.12511","journal-title":"Mov Disord Clin Pract"},{"key":"2815_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","volume":"7","author":"S Schade","year":"2020","unstructured":"Schade S, Mollenhauer B, Trenkwalder C (2020) Levodopa Equivalent Dose Conversion factors: an updated proposal including opicapone and safinamide. Mov Disord Clin Pract 7:343\u2013345. https:\/\/doi.org\/10.1002\/mdc3.12921","journal-title":"Mov Disord Clin Pract"},{"key":"2815_CR35","doi-asserted-by":"publisher","unstructured":"Schirinzi T, Zenuni H, Grillo P et al (2022) Tau and Amyloid-\u03b2 peptides in serum of patients with Parkinson\u2019s Disease: correlations with CSF levels and clinical parameters. Front Neurol 13. https:\/\/doi.org\/10.3389\/fneur.2022.748599","DOI":"10.3389\/fneur.2022.748599"},{"key":"2815_CR36","doi-asserted-by":"publisher","first-page":"e0123231","DOI":"10.1371\/journal.pone.0123231","volume":"10","author":"JS Schneider","year":"2015","unstructured":"Schneider JS, Sendek S, Yang C (2015) Relationship between motor symptoms, Cognition, and demographic characteristics in treated Mild\/Moderate Parkinson\u2019s Disease. PLoS ONE 10:e0123231. https:\/\/doi.org\/10.1371\/journal.pone.0123231","journal-title":"PLoS ONE"},{"key":"2815_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.36.040196.000503","volume":"36","author":"NA Simonian","year":"1996","unstructured":"Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83\u2013106. https:\/\/doi.org\/10.1146\/annurev.pa.36.040196.000503","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2815_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo G, Williams SM, Tishkoff SA (2019) The missing diversity in Human Genetic studies. Cell 177:26\u201331. https:\/\/doi.org\/10.1016\/j.cell.2019.02.048","journal-title":"Cell"},{"key":"2815_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","volume":"62","author":"M Smeyne","year":"2013","unstructured":"Smeyne M, Smeyne RJ (2013) Glutathione metabolism and Parkinson\u2019s Disease. Free Radic Biol Med 62:13\u201325. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.05.001","journal-title":"Free Radic Biol Med"},{"key":"2815_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/1353-8020(96)00014-4","volume":"2","author":"MCMJ Stroombergen","year":"1996","unstructured":"Stroombergen MCMJ, Waring RH, Bennett P, Williams AC (1996) Determination of the GSTM1 gene deletion frequency in Parkinson\u2019s disease by allele specific PCR. Parkinsonism Relat Disord 2:151\u2013154. https:\/\/doi.org\/10.1016\/1353-8020(96)00014-4","journal-title":"Parkinsonism Relat Disord"},{"key":"2815_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-2011-110284","volume":"26","author":"LL Torres","year":"2011","unstructured":"Torres LL, Quaglio NB, De Souza GT et al (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer\u2019s Disease. JAD 26:59\u201368. https:\/\/doi.org\/10.3233\/JAD-2011-110284","journal-title":"JAD"},{"key":"2815_CR42","first-page":"178","volume-title":"Encyclopedia of behavioral medicine","author":"J Upton","year":"2013","unstructured":"Upton J (2013) Beck Depression Inventory (BDI). In: Gellman MD, Turner JR (eds) Encyclopedia of behavioral medicine. Springer, New York, NY, pp 178\u2013179"},{"key":"2815_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0303-8467(98)00009-2","volume":"100","author":"BAJ Veldman","year":"1998","unstructured":"Veldman BAJ, Wijn AM, Knoers N et al (1998) Genetic and environmental risk factors in Parkinson\u2019s disease. Clin Neurol Neurosurg 100:15\u201326. https:\/\/doi.org\/10.1016\/S0303-8467(98)00009-2","journal-title":"Clin Neurol Neurosurg"},{"key":"2815_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord 19:1306\u20131312. https:\/\/doi.org\/10.1002\/mds.20153","journal-title":"Mov Disord"},{"key":"2815_CR45","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","volume":"27","author":"K Wakabayashi","year":"2007","unstructured":"Wakabayashi K, Tanji K, Mori F, Takahashi H (2007) The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology 27:494\u2013506. https:\/\/doi.org\/10.1111\/j.1440-1789.2007.00803.x","journal-title":"Neuropathology"},{"key":"2815_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37\u201349. https:\/\/doi.org\/10.1016\/0022-3956(82)90033-4","journal-title":"J Psychiatr Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02815-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T15:40:48Z","timestamp":1736955648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02815-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2815"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02815-w","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}